UKCF gene therapy consortium tracking study: Sputum and serum calprotectin are useful novel measurements in CF exacerbation

Geahča maid

• EVALUATION OF SAFETY AND GENE EXPRESSION WITH A SINGLE DOSE OF PGM169/GL67A ADMINISTERED TO THE NOSE AND LUNG OF INDIVIDUALS WITH CF: THE UK CF GENE THERAPY CONSORTIUM "PILOT STUDY"
  Dahkki: Davies, J, et al.
  Almmustuhtton: (2009)
• EVALUATION OF SAFETY AND GENE EXPRESSION WITH A SINGLE DOSE OF PGM169/GL67A ADMINISTERED TO THE NOSE AND LUNG OF INDIVIDUALS WITH CYSTIC FIBROSIS: THE UK CF GENE THERAPY CONSORTIUM "PILOT STUDY''
  Dahkki: Davies, J, et al.
  Almmustuhtton: (2009)
• UPDATE ON THE UK CF GENE THERAPY CONSORTIUM MULTIDOSE, NON-VIRAL, GENE THERAPY TRIAL
  Dahkki: Alton, E, et al.
  Almmustuhtton: (2012)
• UPDATE ON THE UK CF GENE THERAPY CONSORTIUM MULTIDOSE, NON-VIRAL, GENE THERAPY TRIAL
  Dahkki: Alton, E, et al.
  Almmustuhtton: (2012)
• Update on the UK CF Gene Therapy Consortium Multidoes, non-viral, gene therapy trial
  Dahkki: Alton, E, et al.
  Almmustuhtton: (2012)